ArticleAmerican journal of cancer therapy and pharmacology2016

The role of β-elimination for the clinical activity of hypomethylating agents and cyclophosphamide analogues.

Haritha Reddy et al.PubMed ↗Full text ↗

No numbers read from the abstract.